Table 3 Clinical characterizations of BRCA1- and MGMT-methylated ovarian cancer patients
From: Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters
Patient no. | Age | Type | Grade | BRCA1 | MGMT |
|---|---|---|---|---|---|
2 | 54 | Clear cell carcinoma | Advanced | Meth | Meth |
13 | 54 | Serous carcinoma | High | Meth | Meth |
36 | 55 | Ovarian serous carcinoma | High | Meth | Meth |
50 | 43 | Ovarian serous carcinoma. | High | Meth | Meth |
23 | 40 | Serous carcinoma | High | Mut/Meth | Meth |
38 | 54 | Serous carcinoma | ND | Mut/Meth | Un Meth |
7 | 57 | Papillary serous carcinoma | High | Meth | Un Meth |
24 | 53 | Serous adenocarcinoma | 3 | Meth | Un Meth |
27 | 47 | Serous carcinoma involving uterus | High | Meth | Un Meth |
52 | 67 | ovarian adenocarcinoma | High | Meth | Un Meth |
59 | 53 | ovarian serous carcinoma | High | Meth | Un Meth |
71 | 38 | Ovarian serous carcinoma | ND | Meth | Un Meth |
29 | 47 | Carcinoma of the right ovary | High | Meth | Un Meth |
6 | 58 | Papillary serous carcinoma | High | Mut | Meth |
14 | 34 | Serous adenocarcinoma | High | Mut | Meth |
47 | 65 | Poorly differentiated adenocarcinoma | ND | Mut | Meth |
17 | 66 | serous ovarian carcinoma | ND | Mut | Meth |
69 | 41 | Ovarian serous carcinoma | ND | Mut | Meth |
4 | 38 | Clear cell carcinoma | GII | WT | Meth |
9 | 46 | papillary serous cancer | High | WT | Meth |
16 | 67 | Serous adenocarcinoma | High | WT | Meth |
44 | 88 | Metastatic granulosa cell tumor | ND | WT | Meth |
55 | 43 | serous carcinoma | High | WT | Meth |
60 | 49 | Granulosa cell tumor | ND | WT | Meth |
79 | 44 | Mucinous cyst adenocarcinoma | ND | WT | Meth |